Abstract

With the exception of the extra protective effect of beta blockers given shortly after a myocardial infarction and the minor additional effect of calcium channel blockers in preventing stroke, all the classes of blood pressure lowering drugs have a similar effect in reducing CHD events and stroke for a given reduction in blood pressure so excluding material pleiotropic effects. The proportional reduction in cardiovascular disease events was the same or similar regardless of pretreatment blood pressure and the presence or absence of existing cardiovascular disease. Guidelines on the use of blood pressure lowering drugs can be simplified so that drugs are offered to people with all levels of blood pressure. Our results indicate the importance of lowering blood pressure in everyone over a certain age, rather than measuring it in everyone and treating it in some.

Keywords

MedicineBlood pressureStroke (engine)Context (archaeology)Myocardial infarctionPlaceboClinical trialMeta-analysisInternal medicineRandomized controlled trialRelative riskConfidence intervalIntensive care medicinePhysical therapyAlternative medicinePathology

Affiliated Institutions

Related Publications

Publication Info

Year
2009
Type
review
Volume
338
Issue
may19 1
Pages
b1665-b1665
Citations
2727
Access
Closed

External Links

Citation Metrics

2727
OpenAlex

Cite This

M R Law, Joan K. Morris, Nicholas Wald (2009). Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ , 338 (may19 1) , b1665-b1665. https://doi.org/10.1136/bmj.b1665

Identifiers

DOI
10.1136/bmj.b1665